Drug Companies, their Patenting Strategies and High-Cost Pharmaceuticals: An Empirical Investigation. Pharmaceuticals are a vital part of clinical services that maintain and improve Australia's health; they are also costly, absorbing a substantial proportion of the national health expenditures. By conferring market protections, the patent system helps the manufacturers of pharmaceuticals to recoup the high costs of research associated with developing new products. Abuses of the patent system by ....Drug Companies, their Patenting Strategies and High-Cost Pharmaceuticals: An Empirical Investigation. Pharmaceuticals are a vital part of clinical services that maintain and improve Australia's health; they are also costly, absorbing a substantial proportion of the national health expenditures. By conferring market protections, the patent system helps the manufacturers of pharmaceuticals to recoup the high costs of research associated with developing new products. Abuses of the patent system by pharmaceutical manufacturers have the potential to stifle competition and inappropriately raise the costs of pharmaceuticals to society. This innovative, cross-disciplinary, research will investigate the existence of abusive patents and, if necessary, propose reforms that will prevent further abuse and reduce the size of the health budget. Read moreRead less
Regulating Medical Nanotechnology in Australia: Developing Practical Improvements in Safety and Cost-Effectiveness Analysis. This Project will provide policy makers with previously unavailable detailed information and well developed, innovative regulatory options, on how best to ensure safe and cost-effective use of one of the fastest growing areas of Australian research and development: medical nanotechnology. The Project will benefit Australian healthcare workers and patients who will increasi ....Regulating Medical Nanotechnology in Australia: Developing Practical Improvements in Safety and Cost-Effectiveness Analysis. This Project will provide policy makers with previously unavailable detailed information and well developed, innovative regulatory options, on how best to ensure safe and cost-effective use of one of the fastest growing areas of Australian research and development: medical nanotechnology. The Project will benefit Australian healthcare workers and patients who will increasingly be exposed to, and concerned about, the risks of medical nanotechnology. It will help to facilitate export and institutional uptake of Australian medical nanotechnology products, by ensuring they comply with world's best practise safety standards and offer value for public expenditure. Read moreRead less